
Tetrahedron p. 7267 - 7276 (1993)
Update date:2022-08-11
Topics:
Baciocchi
Lanzalunga
Benzyltrimethylsilanes react with iodosylbenzene in the presence of either iron(III) or magnanese(III) tetrakis(pentafluorophenyl)porphyrin (TFPPM, with M = Fe, Mn) to give α-hydroxybenzyltrimethylsilanes, which are then rapidly converted into the corresponding benzaldehydes in the reaction medium. In these reactions the active species is the metal-oxo complex. TFPPM(V) = O, formed by iodosylbenzene and TFPPM. A relative reactivity study for a series of ring substituted benzyltrimethylsilanes has shown that when M = Fe, the reaction is quite selective (ρ = -1.85), with the m-MeO substituent exhibiting a much higher reactivity than expected. When M = Mn, a lower ρ value (-1.15) is observed and no anomalous reactivity is found with the m-MeO group. These result suggest that the side-chain hydroxylation of benzyltrimethylsilane by TFPPMn(V) = O occurs by the well known hydrogen atom transfer mechanism. For the corresponding reactions induced by TFPPFe(V) = O a coupled proton/electron transfer mechanism, which might involve the formation of a charge-transfer complex, seems more likely.
View More
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Yicheng Goto Pharmaceuticals Co.,Ltd.
Contact:+86 710 3423122
Address:5th Floor,East Gate of Building #2,Servo-Industrial Park,1st Qilin Road,Xiangyang,Hubei,China
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
Laizhou City Laiyu Chemical CO.,Ltd
Contact:+86-535-2719337/2719339
Address:Chenggang road zhuyou laizhou City Shangdong China
Doi:10.1021/jf703785p
(2008)Doi:10.1016/j.apcata.2016.11.013
(2017)Doi:10.1039/c9ra09997b
(2020)Doi:10.1021/acs.molpharmaceut.8b00518
(2018)Doi:10.1007/s11243-013-9788-3
(2014)Doi:10.1016/S0031-9422(03)00437-0
(2003)